WELLS FARGO & COMPANY/MN - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 46 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$2,609,635
+226.7%
2,614,000
+221.1%
0.00%
Q4 2022$798,738
-1.0%
814,000
-2.2%
0.00%
Q3 2022$807,000
+4647.1%
832,000
+4522.2%
0.00%
Q2 2022$17,000
-5.6%
18,0000.0%0.00%
Q1 2022$18,0000.0%18,0000.0%0.00%
Q4 2021$18,000
-98.8%
18,000
-98.8%
0.00%
Q3 2021$1,466,000
-2.5%
1,492,000
-2.5%
0.00%
Q2 2021$1,504,000
+2.0%
1,530,0000.0%0.00%
Q1 2021$1,475,000
+40.6%
1,530,000
+31.4%
0.00%
Q4 2019$1,049,0001,164,0000.00%
Other shareholders

There were no reported owners of SUPERNUS PHARMACEUTICALS INC in Q2 2021.

NameSharesValueWeighting ↓
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders